Drug-Loaded Nanoparticles

Nanotechnology is an emerging field of science and engineering that involves the manipulation of matter at the nanoscale, which is usually 1-100 nanometers in size. Drug-loaded nanoparticles (DLNPs) are an important application of nanotechnology in the medical field. They are nanoscale particles that are designed to deliver drugs or other therapeutic agents to targeted tissues or cells in the body. DLNPs are typically composed of a core, shell, and active agent. The core can be composed of organic or inorganic materials such as lipids, polymers, or metallic nanoparticles. The shell is typically composed of a biocompatible material such as a polymer or lipid. The active agent is the drug or therapeutic molecule that is encapsulated within the DLNP. DLNPs offer several advantages over traditional drug delivery systems. They can be designed to be biocompatible, biodegradable, and to target specific tissue or cell types. They can also be designed to release their payloads over a controlled period of time, which can improve drug efficacy and reduce side effects. They can also be used to deliver multiple drugs or agents in a single particle, which can reduce the number of injections needed. DLNPs are being studied and developed for a variety of medical applications, including cancer treatment, gene therapy, tissue engineering, and vaccine delivery. They offer the potential to improve drug delivery, reduce side effects, and improve therapeutic efficacy.